Center for Bioethics Papers

Document Type

Journal Article

Date of this Version

12-1-2006

Comments

Postprint version. Published in Nature Biotechnology, Volume 24, Issue 12, December 2006, pages 1472-1473.
Publisher URL: http://dx.doi.org/10.1038/nbt1206-1472

Abstract

The paper in your April issue by Lai et al. entitled "Generation of cloned transgenic pigs rich in omega-3 fatty acids" (Nat. Biotechnol. 24, 435–436, 2006) perfectly captures the fundamental problem with American biotech research. That problem is that scientists pursue their research agenda to further scientific knowledge - all well and good - but when the project succeeds they invent problems for which their research results can be marketed as a solution. This unreflective move from 'pure science' to commercialization may end up as biotech's undoing.

Included in

Biotechnology Commons

Share

COinS
 

Date Posted: 22 May 2007

This document has been peer reviewed.